FDA Panel Gives Nod to Affymax Drug for Anemia - Fox News PDF Print
Fox News
A new Affymax Inc drug won expert backing to treat anemia in patients with chronic kidney disease who are on dialysis. A Food and Drug Administration advisory panel voted 15-1 on Wednesday, with one abstention, that peginesatide's benefits outweighed ...
Anemia In Dialysis Patients - Peginesatide Gets Green Light From FDA Advisory ... Medical News Today
FDA Panel Endorses ESA for Patients on Dialysis MedPage Today
Nektar Reports Affymax Announced FDA Advisory Committee Voted in Favor of

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.